Zusammenfassung
CED sind keine psychosomatischen Erkrankungen (psychische Faktoren sind Mitursache der Erkrankung) im engeren Sinne. Der Krankheitsverlauf und die Therapie können zu psychischen und sozialen Belastungen der Patienten führen (somatopsychische Erkrankung). Seelische Faktoren (Stress, Depression) können einen ungünstigen Einfluss auf den Krankheitsverlauf haben (psychosomatische Erkrankung im weiteren Sinne). Gastroenterologen sollen psychosoziale Belastungen durch die CED und psychologische Behandlungswünsche der Patienten erfassen. Außerdem sollten behandelnde Ärzte auf die Möglichkeit einer Unterstützung durch Selbsthilfeorganisationen hinweisen. Eine psychotherapeutische Behandlung soll CED-Patienten mit psychischen Begleiterkrankungen empfohlen und aktiv vermittelt werden. Antidepressiva können gastrointestinale und seelische Beschwerden lindern. Eine Kooperation von Gastroenterologen und ärztlichen und psychologischen Psychotherapeuten mit Erfahrung in der psychosozialen Betreuung von CED-Patienten ist sinnvoll.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Alexander F (1950) Psychosomatic medicine. Its principles and applications. Norton, New York
Auer PG, Enck P, Häuser W, Stengel A, Storr M, Langhorst J, AG Psychosomatik in der Gastroenterologie der DGVS (2018) Psychosomatics in gastroenterology – statement of the Work Group for Psychosomatics in Gastroenterology of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Z Gastroenterol 56:684–689
Authors, Collaborators (2019) Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS). Z Gastroenterol 57:162–241.
Ballou S, Keefer L (2017) Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clin Transl Gastroenterol. 8:e214
Berding A, Witte C, Gottschald M, Kaltz B, Weiland R, Gerlich C, Reusch A, Kruis W, Faller H (2017) Beneficial effects of education on emotional distress, self-management, and coping in patients with inflammatory bowel disease: a prospective randomized controlled study. Inflamm Intest Dis 1:182–190
Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M (2010) A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 105:1994–2002
Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN (2011) Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 17:590–598
Biedermann L, Fournier N, Misselwitz B et al (2015) High rates of smoking especially in female Crohn’s disease patients and low use of supportive measures to achieve smoking cessation-data from the Swiss IBD Cohort Study. J Crohns Colitis 9:819–829
Blumenstein I, McDermott E, Keegan D et al (2013) Sources of information and factual knowledge in Europeans with inflammatory bowel diseases: a cross-cultural comparison between German and Irish patients. J Crohns Colitis 7:e331–e336
Bokemeyer B, Hardt J, Hüppe D et al (2013) Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. J Crohns Colitis 7:355–368
Borgaonkar MR, Townson G, Donnelly M, Irvine EJ (2002) Providing disease-related information worsens health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 8:264–269
Bregenzer N, Lange A, Fürst A et al (2005) Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being. Z Gastroenterol 43:367–371
Büsch K, da Silva SA, Holton M, Rabacow FM, Khalili H, Ludvigsson JF (2014) Sick leave and disability pension in inflammatory bowel disease: a systematic review. J Crohns Colitis 8:1362–1377
Cámara RJ, Ziegler R, Begré S, Schoepfer AM, von Känel R, the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) group (2009) The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion 80:129–139
Cho R, Wickert NM, Klassen AF, Tsangaris E, Marshall JK, Brill H (2018) Identifying needs in young adults with inflammatory bowel disease: a qualitative study. Gastroenterol Nurs 41:19–28
Cosnes J, Beaugerie L, Carbonnel F, Gendre JP (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120:1093–1099
Crohn BB, Ginzburg L, Oppenheimer GD (1932) Regional ileitis. A pathologic and clinical entity. JAMA 99:1323–1328
Ducharme-Bénard S, Côté-Daigneault J, Lemoyne M, Orlicka K, Lahaie R, Weber A, Bouin M (2016) Patients with inflammatory bowel disease are unaware of the impact of smoking on their disease. J Clin Gastroenterol. 50:490–497
Enck P, Schäfer R (1996) Psychosoziale Faktoren beim M. Crohn: eine Übersicht [Psychosocial factors in Crohn disease – an overview]. Z Gastroenterol 34:708–713
Graff LA, Walker JR, Bernstein CN (2009) Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 15:1105–1118
Häuser W, Janke KH, Klump B, Hinz A (2011) Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 17:621–632
Häuser W, Moser G, Klose P, Mikocka-Walus A (2014) Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review. World J Gastroenterol 20:3663–3671
Hüppe A, Langbrandtner J, Raspe H (2013) Komplexe psychosoziale Problemlagen bei Morbus Crohn und Colitis ulcerosa – fragebogengestütztes Assessment als erster Schritt zur Aktivierung von Patientinnen und Patienten [Assessing complex health problems of patients with IBD – first step to patient activation]. Z Gastroenterol 51:257–270
Jäghult S, Larson J, Wredling R, Kapraali M (2007) A multiprofessional education programme for patients with inflammatory bowel disease: a randomized controlled trial. Scand J Gastroenterol 42:1452–1459
Kamat N, Rajan Mallayasamy S, Sharma PSVN, Kamath A, Pai CG (2018) Video assisted patient education improves compliance with follow up and depression scores in inflammatory bowel diseases. Postgrad Med 130:355–360
Knowles SR, Monshat K, Castle DJ (2013) The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis 19:2704–2715
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A (2018) Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part II. Inflamm Bowel Dis 24:966–976
Langhorst J, Hofstetter A, Wolfe F, Häuser W (2013) Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study. Inflamm Bowel Dis 19:2380–2386
Lunney PC, Kariyawasam VC, Wang RR, Middleton KL, Huang T, Selinger CP, Andrews JM, Katelaris PH, Leong RW (2015) Smoking prevalence and its influence on disease course and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 42:61–70
Macer BJ, Prady SL, Mikocka-Walus A (2017) Antidepressants in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 23:534–550
McCombie AM, Mulder RT, Gearry RB (2013) How IBD patients cope with IBD: a systematic review. J Crohns Colitis 7:89–106
McCombie A, Gearry R, Andrews J, Mulder R, Mikocka-Walus A (2016) Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial. Inflamm Bowel Dis 22:171–181
Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews JM (2015) Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterol 15:54
Mikocka-Walus A, Knowles SR, Keefer L, Graff L (2016) Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis 22:752–762
Preiß JC, Bokemeyer B, Buhr HJ et al (2014) Updated German clinical practice guideline on „Diagnosis and treatment of Crohn’s disease“ 2014. Z Gastroenterol. 52:1431–1484
Rothe HM, Cuntz U (2014) Psychosomatische Institutsambulanzen in der sektorübergreifenden Versorgung. Ärztl Psychother 9:196–200
Schaefert R, Häuser W (2017) Chronisch entzündliche Darmerkrankungen. In: Köhle K, Herzog W, Joraschlky P, Kruse K, Langewitz W, Söllner W (Hrsg) Uexküll. Psychosomatische Medizin, 8. Aufl. Elsevier, München, S 919–920
Selinger CP, Robinson A, Leong RW (2011) Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease. Expert Opin Drug Saf 10:863–870
Szigethy EM, Allen JI, Reiss M, Cohen W, Perera LP, Brillstein L, Cross RK, Schwartz DA, Kosinski LR, Colton JB, LaRusso E, Atreja A, Regueiro MD (2017) White paper AGA: the impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 15:986–997
Timmer A, Preiss JC, Motschall E, Rücker G, Jantschek G, Moser G (2011) Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2:CD006913
To N, Gracie DJ, Ford AC (2016) Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn’s disease. Aliment Pharmacol Ther 43:549–561
Van Assche G, Dignass A, Bokemeyer B, the European Crohn’s and Colitis Organisation et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis, part 3: special situations. J Crohns Colitis 7:1–33
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Häuser, W. (2020). Psychosomatik. In: Hoffmann, J.C., Klump, B., Kroesen, A., Siegmund, B. (eds) Chronisch-entzündliche Darmerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59104-8_36
Download citation
DOI: https://doi.org/10.1007/978-3-662-59104-8_36
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59103-1
Online ISBN: 978-3-662-59104-8
eBook Packages: Medicine (German Language)